Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v2-EN
Language English English
Date Updated 2020-01-22 2020-01-17
Drug Identification Number 02263254 02263254
Brand name CIPRALEX -20MG CIPRALEX -20MG
Common or Proper name ESCITALOPRAM ESCITALOPRAM
Company Name LUNDBECK CANADA INC LUNDBECK CANADA INC
Ingredients ESCITALOPRAM ESCITALOPRAM
Strength(s) 20MG 20MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size Blister pack of 30 tablets / Plaquette alvéolée de 30 comprimés Blister pack of 30 tablets / Plaquette alvéolée de 30 comprimés
ATC code N06AB N06AB
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2020-01-13 2020-01-13
Estimated end date 2020-02-14
Actual end date 2020-01-21
Shortage status Resolved Actual shortage
Company comments minor graphic error minor graphic error
Health Canada comments